About 64,658 results

ALLMedicine™ Cirrhosis Center

Research & Reviews  19,978 results

Systemic treatment for unresectable hepatocellular carcinoma.
World Journal of Gastroenterology; Leowattana W, Leowattana T et. al.

Mar 28th, 2023 - Hepatocellular carcinoma (HCC) is most commonly found in the context of liver cirrhosis and, in rare cases, in a healthy liver. Its prevalence has risen in recent years, particularly in Western nations, due to the increasing frequency of non-alcoh...

Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associate...
Clinical and Translational Gastroenterology; McLean Diaz P, Vannier A et. al.

Mar 28th, 2023 - We hypothesized that fibroblast growth factor-21 (FGF-21) would be highly expressed in patients with alcohol-associated hepatitis (AH) and could be a novel and biologically relevant predictive biomarker to reliably distinguish severe AH and decomp...

Early paracentesis is associated with better prognosis compared to late or no-paracente...
Liver Transplantation : Official Publication of the Ameri... Patel N, Silvey S et. al.

Mar 28th, 2023 - Guidelines recommend that all hospitalized patients with cirrhosis and ascites receive an early (<24 h from admission) paracentesis. However, national data are not available regarding compliance with and consequences of this quality metric. We uti...

Alcoholic cardiomyopathy in patients with alcoholic liver cirrhosis: a study across 10 ...
European Journal of Gastroenterology & Hepatology; Wang C, Gao H et. al.

Mar 27th, 2023 - Available data regarding cardiomyopathy in patients with alcoholic liver cirrhosis (ALC) are very limited because it often requires multidisciplinary assessments. The study aims to evaluate the prevalence of alcoholic cardiomyopathy in ALC and the...

Relationship between lipid profiles and reduced handgrip strength (dynapenia) in hospit...
European Journal of Gastroenterology & Hepatology; Cui B, Hui Y et. al.

Mar 27th, 2023 - Dynapenia embraces clinical significance and predictive value separated from skeletal muscle loss among cirrhosis. Moreover, alterations in lipid levels may impact muscle function. It has yet to elucidate the relationship between lipid profiles an...

see more →

Guidelines  44 results

Health and cancer risks associated with low levels of alcohol consumption
The Lancet Public Health; Anderson BO, .

Jan 1st, 2023 - The overall risks and harms resulting from alcohol consumption have been systematically assessed and are well documented. According to the latest WHO estimates,1 alcohol consumption contributed to 3 million deaths in 2016 globally and was responsi...

AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in...
Clinical Gastroenterology and Hepatology : the Official C... Flamm SL, Wong F et. al.

Sep 9th, 2022 - The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update is to review the available published evidence and expert advice regarding the clinical management of patients with suspected acute kidney injury ...

AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Dise...
Gastroenterology Long MT, Noureddin M et. al.

Jul 17th, 2022 - Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading etiology for chronic liver disease, affecting >25% of the US and global populations. Up to 1 in 4 individuals with NAFLD have nonalcoholic steatohepatitis, which is associate...

EASL Clinical Practice Guidelines on haemochromatosis.
Journal of Hepatology; ,

Jun 7th, 2022 - Haemochromatosis is characterised by elevated transferrin saturation (TSAT) and progressive iron loading that mainly affects the liver. Early diagnosis and treatment by phlebotomy can prevent cirrhosis, hepatocellular carcinoma, diabetes, arthropa...

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diag...
Endocrine Practice : Official Journal of the American Col... Cusi K, Isaacs S et. al.

May 16th, 2022 - To provide evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other...

see more →

Drugs  874 results see all →

Clinicaltrials.gov  2,530 results

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Mar 23rd, 2023 - Study Description: We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment na(SqrRoot) ve or experienced who have failed a prior treatment (includi...

Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites

Mar 23rd, 2023 - This is a phase 3, multicenter, randomized, controlled, parallel-group, and open-label clinical study to evaluate the efficacy of standard medical treatment (SMT) + Albutein 20% administration versus SMT alone in subjects with decompensated cirrho...

Cirrhosis Medical Home

Mar 22nd, 2023 - In the Cirrhosis Medical Home, a care coordinator, supported by an interdisciplinary clinical team, will deliver a personalized intervention guided by a set of innovative tools: (i) patient-centered care protocols, (ii) a mobile office, (iii) care...

Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy

Mar 21st, 2023 - At present, there are no clear guidelines as to when antiretroviral therapy for human immunodeficiency virus (HIV) infection should be stopped in the setting of elevated liver enzymes. In large part, this is due to a limited understanding of the n...

A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood ...

Mar 21st, 2023 - This study is open to adults with liver cirrhosis caused by hepatitis B, hepatitis C or nonalcoholic steatohepatitis (NASH). People can join this study if they have high blood pressure in the portal vein (main vessel going to the liver). The purpo...

see more →

News  2,318 results

Breathing easier: The growing adoption of indwelling pleural catheters

Mar 15th, 2023 - Thoracic Oncology Network Interventional Procedures Section The management of recurrent pleural effusions is challenging. Indwelling tunneled pleural catheters (IPCs) have been shown to reduce the need for additional pleural procedures, admissions.

Screen All Adults for Hepatitis B, CDC Says

Mar 9th, 2023 - All adults should be tested for a hepatitis B virus (HBV) infection at least once in their lifetime, and a wider range should get periodic retesting, according to new CDC recommendations. The report recommended moving from a risk-based approach to...

An earlier hep B biomarker for clinical outcomes?
Jim Kling, MDedge News

Mar 8th, 2023 - Low serum levels of the hepatitis B core-related antigen (HBcrAg) could be an early biomarker of a functional cure of a hepatitis B infection, according to new findings from a retrospective study. A drop in HBcrAg predicted the seroclearance of he.

Palliative radiotherapy successfully reduces end-stage liver cancer pain
Randy Dotinga

Jan 25th, 2023 - Most patients with end-stage hepatocellular carcinoma experience pain, but when it’s severe, how best to control the pain is debatable. A number of studies, including one recently presented at the ASCO Gastrointestinal Cancers Symposium 2023, show.

Geriatrician advises on use of vitamin D supplementation, lecanemab, and texting for her patients
Mengru Wang, MD, MPH

Jan 20th, 2023 - This article discusses updates in geriatrics from studies published in 2022 to early 2023. The topics covered include vitamin D supplementation and incident fractures, the association of social isolation and dementia, and the release of lecanemab,.

see more →

Patient Education  119 results see all →